• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

tirzepatide

pause button on blue background
Pharma

Lilly pauses UK orders on its diabetes and obesity med Mounjaro

Lilly will resume taking U.K. Mounjaro requisitions Sept. 1 but has temporarily implemented a “month-end cut off for orders,” a spokesperson said.
Fraiser Kansteiner Aug 28, 2025 11:08am
Mounjaro tirzepatide

Mounjaro measures up to Trulicity in Eli Lilly cardio trial

Jul 31, 2025 8:12am
compounding compounding pharmacy drug preparation formulation

Experts hold line against mass compounding of GLP-1 obesity meds

Jun 27, 2025 10:36am
law and order concept

Compounders ordered to halt production of semaglutide knockoffs

Apr 25, 2025 10:25am
tortoise hare

BMO says Lilly is pulling ahead of Novo in obesity market battle

Apr 17, 2025 4:30pm
Zepbound tirzepatide

Lilly files lawsuit against spa for selling repackaged Zepbound

Apr 7, 2025 5:00am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings